AlphaStreet Newsdesk powered by AlphaStreet Intelligence
OKUR|EPS -$0.31|Web Loss $15.3MOnkure Therapeutics Inc (OKUR) reported Q2 2026 primary and diluted earnings of -$0.31 per share.
Backside line confirmed a web lack of $15.3M.
Wall Avenue consensus stands at 6 purchase, 2 maintain, 0 promote. The lack of $0.31 per share narrowed 72.8% from the $1.14 loss in Q2 2025.
This content material is for informational functions solely and shouldn’t be thought-about funding recommendation. AlphaStreet Intelligence analyzes monetary information utilizing AI to ship quick and correct market info. Human editors confirm content material.
